DUBLIN–(BUSINESS WIRE)–The “3D Bioprinting Market – Global Outlook and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.
The global 3D Bioprinting market is expected to grow at a CAGR of 18.45% during 2022-2027.
The 3D Bioprinting is a technique that allows the production of biocompatible materials and complex 3D functional living tissues. It has enabled numerous researchers and manufacturers to mimic the natural tissue microenvironment into an in-house printed 3D tissue model. It has an immense impact in the field of medicine and healthcare.
The 3D bioprinting market focuses on developing application-specific bio-inks and new biomaterials, which are crucial in advancing Bio-printing tissues and organs for clinical use. Bioprinters and bio-printed tissues have gained significant interest in medicine and pharmaceutics. Besides, bioprinting technology has a broad utility in various application areas such as tissue engineering and regenerative medicine (RM), transplantation, cancer research and drug screening, and high-throughput assays.
Bioprinting technology has the most recognized application in tissue engineering. Bioprinters are used to manufacture scaffolds and fabricate anatomically correct patient-specific constructs. In vitro bio-printed tissues such as skin, nerve and bone have been implanted on animals to evaluate their functionality, neovascularization, and engraftment with the host. Bioprinting’s future application is expected to be mostly in organ transplantation and drug & toxicity screening.
4D bioprinting can overcome many limitations of 3D printing; hence, it has become a new field in RM and tissue engineering markets. When compared to 3D printing, 4D printing offers various advantages such as fast growth of smart and multi-materials, more flexible and deformable structures, and can add more potential applications to both 4D and 3D printing. The emergence of 4D bio-printing is gaining momentum in disease management and healthcare innovation.
Technological Advancements
One of the biggest trends in technological innovations is the development of magnetic bioprinters, Organ. But, a magnetic bioprinter was developed by a Russian company, 3D Bioprinting Solutions. Furthermore, the Japanese company Cyfuse Biomedical developed a platform that allows the creation of scaffold-free tissues using the Kenzan Bio-printing method to manipulate spheroids. Conversely, some companies, such as Germany-based Cellbricks, prefer to produce complex 3D printed cell culture structures with a proprietary non-commercial stereolithography-based Bio-printing platform.
The enhancement in printing resolution, speed, and cost reduction are common challenges to be faced in the coming future. Germany-based Cellbricks prefer to produce complex 3D-printed cell culture structures with a proprietary non-commercial stereolithography-based Bio-printing platform. Furthermore, some enterprises try to propose bioprinters with more degrees of freedom to increase system flexibility and the range of printable features, like the American company Advanced Solutions, which has patented a six-axis robotic extrusion-based bioprinter arm, BioAssembleBot 400, which can load up to ten independent biomaterials during a single print run.
Poietis, a France based Bio-printing company, focuses on laser-assisted Bio-printing combined with extrusion-based and inkjet-based technologies supported via a proprietary privacy impact assessment (PIA) software to reconstitute the 3D picture of a complete tissue with all layers. Aspect Biosystems, a Canada-based Bio-printing company, attempts to achieve improved accuracy in developing microfluidic platforms equipped with an on-printhead crosslinking system that can print bioinks with a coaxial shell.
Key Questions Answered:
1. How big is the global 3D bioprinting market?
2. What is the growth rate of the bio-printing market?
3. What are the growth factors in the bio-printing market?
4. Who are the key players in the bio-printing market?
5. What are the latest trends in the bio-printing market?
Market Segmentation
by Components
3d Bioprinters
Bio-Inks
by Application
Research
Clinical
by Material
Living Cells
Hydrogels
Extracellular Matrices
Others
by End-User
RO & AT
Biopharmaceutical Companies
RM Companies
Others
by Geography
North America
US
Canada
Europe
Germany
France
UK
Spain
Italy
APAC
Japan
China
South Korea
India
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
South Africa
Key Vendors
Organovo Holdings
BICO
Advanced Solutions (ASI)
Other Prominent Vendors
Aspect Biosystems
BIOLIFE4D
Brinter
Cellbricks
CollPlant
Cyfuse Biomedical
3D Bio-printing Solutions
3D Systems
3DBio Therapeutics
Desktop Metal
Foldink
Formlabs
FELIXprinters
Fluicell
GeSiM
Hangzhou Jienuofei Biotechnology
Inventia Life Science
LIfe SI
Medprin
Next Big Innovation Labs
Ourobionics
Poietis
Precise Bio
Prellis Biologics
ROKIT Healthcare
REGENHU
Stratasys
TissueLabs
For more information about this report visit https://www.researchandmarkets.com/r/9xzhh0
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
